# clm_3A1E7B4FAF72

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: quarterly_revenue  
value: 9,498,600,000 United States dollar  
valid_from: 2023-09-30  
valid_to: 2024-03-31  
published: 2023-11-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_1AD340C3A5DB  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company quarterly revenue: 9,498,600,000 United States dollar", as of 2023-09-30 (until 2024-03-31). Claim clm_3A1E7B4FAF72, https://asof.is/claim/clm_3A1E7B4FAF72, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947823000284/0000059478-23-000284-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Revenues in 10-Q Q3 FY2023, filed 2023-11-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947823000284/0000059478-23-000284-index.htm (primary, SEC EDGAR 10-Q Q3 FY2023, published 2023-11-02)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_revenue | 8,312,100,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_3A1E7B4FAF72](/claim/clm_3A1E7B4FAF72.md) | [clm_D152AA3878B8](/claim/clm_D152AA3878B8.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.